Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus

Clinical trial NCT06297408 · UNKNOWN

Trial details

NCT number: NCT06297408
Sponsor: Shanghai Ming Ju Biotechnology Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2024-03-01
Primary completion: 2025-05-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.